LONG FACTOR CERTIFICATE - UCB Stock

ZSQ8H

DE000GP569M5

Market Closed - Euronext Paris 12:30:01 2024-06-13 pm EDT
36.5 ^EUR	+3.84%

Current month	+79.10%
1 month	+163.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : Financial Reporting Document	Jun. 13	PU
European shares steady after French political tremors, eyes on Fed	Jun. 11	RE
UCB : Acquisition of own shares	May. 31	PU
UCB : Commitment to Innovation in Drug Development	May. 29	PU

More news

Quotes 5-day view

Date	Price	Change
24-06-13	36.5	+3.84%
24-06-12	35.15	+39.54%
24-06-11	25.19	+7.42%
24-06-10	23.45	-0.59%
24-06-07	23.59	+3.15%

Real-time Euronext Paris

Last update June 13, 2024 at 12:30 pm EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	UCB
Issuer	Goldman Sachs
	ZSQ8H
ISIN	DE000GP569M5
Date issued	2023-05-31
Strike	124 €
Maturity	Unlimited
Parity	0.34 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	38.29 €
Lowest since issue	0.11 €
Spread	1.5 €
Spread %	4.02%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

136 EUR

Average target price

135 EUR

Spread / Average Target

-0.72%

Consensus